Update 1 Eu Charge Sheet Tells Illumina To Swiftly Unwind Grail Deal
Result for: Update 1 Eu Charge Sheet Tells Illumina To Swiftly Unwind Grail Deal
Dec 5, 2022 By Foo Yun Chee. BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail ,...
BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina (ILMN.O) to unwind its acquisition of biotech firm Grail (GRAL.O),...
Dec 5, 2022 BRUSSELS (Reuters) -EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail, three months after blocking...
The Commission thus orders the following measures: (i) divestment measures requiring Illumina to unwind the transaction with GRAIL; and (ii) transitional measures that Illumina and GRAIL need to comply with until Illumina has dissolved the transaction. Specifically, the divestment measures must be implemented in line with the following principles:
Oct 12, 2023 By RAF CASERT. Updated 4:01 AM PDT, October 12, 2023. BRUSSELS (AP) The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in the 27-nation bloc.
Dec 5, 2022 BRUSSELSThe European Union on Monday set out the details of a planned order requiring Illumina Inc. to unwind its $7.1 billion acquisition of cancer-test developer Grail Inc.
BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday sent a charge sheet to U.S. life sciences company Illumina ILMN.O outlining proposed measures to unwind its acquisition of...
Oct 12, 2023 Illumina must unwind its $7.1 billion acquisition of cancer-test developer Grail, the European Unions competition watchdog said. The European Commission, which oversees antitrust...
SAN DIEGO, Oct. 13, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), has received an order from the European Commission (EC) directing the company to divest GRAIL. Receipt of the order is an important next step in evaluating divestiture options for GRAIL.
Jul 13, 2022 By Foo Yun Chee. LUXEMBOURG -U.S. life sciences company Illumina on Wednesday lost its challenge against European Union scrutiny of its $8 billion cash-and-stock takeover of Grail, as a top...
Dec 5, 2022 The EU competition enforcer said on Monday that it had sent a statement of objections to Illumina and Grail setting out proposed measures they would have to take to restore competition in the market. The companies can ask for a closed-door hearing and also submit a written response before the EU antitrust watchdog issues a final decision in ...
May 12, 2022 BRUSSELS -EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail, three months after blocking the deal...
Dec 5, 2022 Illumina gets EU antitrust charge sheet to unwind Grail acquisition swiftly The EU competition enforcer said it had sent a statement of objections to Illumina and biotechnology company Grail setting out proposed measures the companies would have to take to restore competition in the market.
Apr 3, 2023 The Federal Trade Commission has ordered Illumina to divest cancer screening company Grail, arguing the $8bn acquisition would damage competition in the US market for life-saving cancer tests.
Dec 5, 2022 BRUSSELS (Reuters) - EU antitrust regulators on Monday sent a charge sheet to U.S. life sciences company Illumina outlining proposed measures to unwind its acquisition of Grail, three months after they blocked the deal on concerns that it would hurt competition.
Dec 5, 2022 EU charge sheet tells Illumina to swiftly unwind Grail deal. December 05, 2022 at 11:22 am EST. BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail , three months after blocking the deal on concerns that it would hurt competition.
Dec 12, 2023 LUXEMBOURG, Dec 12 (Reuters) - Illumina (ILMN.O) on Tuesday accused EU antitrust regulators of over-extending their powers in their scrutiny of its $7.1 billion for Grail (GRAL.O) while...
BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina ILMN.O to unwind its acquisition of biotech firm Grail GRAL.O, three months after blocking the deal on concerns that it would hurt competition.
Dec 5, 2022 EU charge sheet tells Illumina to swiftly unwind Grail deal. EU charge sheet tells Illumina to swiftly unwind Grail deal. Breaking News . Quotes. All Instrument Types. All Instrument Types; Indices; Equities; ETFs; Funds; Commodities; Currencies; Crypto;
Dec 6, 2022 EU antitrust regulators sent a charge sheet to U.S. life sciences company Illumina outlining proposed measures to unwind its acquisition of Grail. Europe Illumina Illumina completed the deal in August last year without first waiting for EU regulatory approval.
BRUSSELS, Dec 5 (Reuters) - EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail , three months after blocking the deal on concerns that it would hurt competition.
Dec 5, 2022 BRUSSELS EU antitrust regulators on Monday proposed measures for U.S. life sciences company Illumina to unwind its acquisition of biotech firm Grail , three
EU charge sheet tells Illumina to swiftly unwind Grail deal. EU charge sheet tells Illumina to swiftly unwind Grail deal Watchlist. Signup/Login. AUS AUS USA UK NZ CA ... Business News Market Updates Economy Personal Finance Stock Market Food & Beverages Energy.
Related Keywords For Update 1 Eu Charge Sheet Tells Illumina To Swiftly Unwind Grail Deal